David Fitchett
Impact in
- Endocrinology, Diabetes and Metabolism top 0.02%
- Diabetes Treatment and Management
- Diabetes Management and Research
-
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
Papers in
-
- Diabetes Treatment and Management 86
- Diabetes Management and Research 22
-
- Acute Myocardial Infarction Research 49
- Cardiovascular Function and Risk Factors 22
- Co-authors
- Bernard ZinmanSilvio E. InzucchiChristoph WannerOdd Erik JohansenJohn M. LachinUli C. BroedlMichaela MattheusStefan Hantel
- Journals
- Canadian Journal of Cardiology (33 papers)American Heart Journal (15 papers)The American Journal of Cardiology (15 papers)European Heart Journal (12 papers)Journal of the American College of Cardiology (8 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
David Fitchett
191 papers receiving 18.1k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Endocrinology, Diabetes and Metabolism 12.8k
- Cardiology and Cardiovascular Medicine 5.9k
- Nephrology 1.8k
- Surgery 6.8k
- Pharmacology 1.5k
Countries citing papers authored by David Fitchett
This map shows the geographic impact of David Fitchett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fitchett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fitchett more than expected).
Fields of papers citing papers by David Fitchett
This network shows the impact of papers produced by David Fitchett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fitchett. The network helps show where David Fitchett may publish in the future.
Co-authors
The 25 scholars most cited alongside David Fitchett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2020 | 12 | |
| 3 | 2019 | 2 | |
| 4 | 2019 | 1 | |
| 5 | Are the cardiovascular risk reductions seen with empagliflozin in the EMPA-REG OUTCOME trial explained by conventional cardiovascular risk factors? | 2017 | 1 |
| 6 | 2016 | 67 | |
| 7 | 2016 | 0 | |
| 8 | 2016 | 20 | |
| 9 | 2014 | 7 | |
| 10 | 2013 | 14 | |
| 11 | Managing cardiometabolic risk in primary care: summary of the 2011 consensus statement. | 2012 | 50 |
| 12 | Prise en charge des risques cardiométaboliques en soins primaires | 2012 | 1 |
| 13 | 2011 | 28 | |
| 14 | 2010 | 70 | |
| 15 | 2008 | 61 | |
| 16 | 2007 | 3 | |
| 17 | Are Canadian guidelines for cholesterol lowering in high-risk patients optimal? | 2005 | 3 |
| 18 | 1997 | 5 | |
| 19 | 1990 | 6 | |
| 20 | 1975 | 27 |
About David Fitchett
David Fitchett is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Internal Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 200 papers that have together received 18.7k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (86 papers), Acute Myocardial Infarction Research (49 papers), Pancreatic function and diabetes (48 papers), Metabolism, Diabetes, and Cancer (40 papers), Cardiac Imaging and Diagnostics (30 papers), Coronary Interventions and Diagnostics (28 papers), Cardiovascular Function and Risk Factors (22 papers) and Diabetes Management and Research (22 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (12.8k citations), Cardiology and Cardiovascular Medicine (5.9k citations), Nephrology (1.8k citations), Surgery (6.8k citations) and Pharmacology (1.5k citations). David Fitchett has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Bernard Zinman, Silvio E. Inzucchi, Christoph Wanner, Odd Erik Johansen, John M. Lachin, Uli C. Broedl, Michaela Mattheus, Stefan Hantel, Erich Bluhmki and Hans J. Woerle. Their work appears in journals such as Canadian Journal of Cardiology, American Heart Journal, The American Journal of Cardiology, European Heart Journal and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.